Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) will launch a new topical product to treat rhinitis and sinusitis. The stock price soared $2.12 to close at $5.55.
Biostar Pharmaceuticals launches new product
October 11, 2016 at 17:34 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.